Professor Hassan Azzazy
Dr. Azzazy is a tenured full professor of Chemistry (2003-present) at the American University in Cairo (AUC). He served as the Chairman of Chemistry Department and Associate Dean for Graduate Studies & Research at the School of Sciences & Engineering, AUC. Prior to joining AUC, Dr. Azzazy was a postdoctoral fellow and assistant professor at University of Maryland School of Medicine, Baltimore, MD (1995-2002). He holds two board certifications in Clinical Chemistry and Molecular Diagnostics from the American Board of Clinical Chemistry, Washington, DC. Dr. Azzazy has over 26 years of experience in biomedical research and currently leads the Novel Diagnostics & Therapeutics research group at AUC. Dr. Azzazy authored 77 publications in refereed journals, 70 conference presentations, and 25 book chapters. He has co-edited two books on “diagnostic enzymology” and “Innovation & Entrepreneurship in Egypt”. According to Scopus, he has H-Index of 21 and 1887 citations. Dr. Azzazy is the co-founder & CTO of the startup company D-Kimia Innovative Diagnostics, LLC which develops affordable diagnostic solutions. He is also the founder and CEO of NanoEbers, LLC which focuses on development of biocompatible nanofibrous wound dressings. Dr. Azzazy is the recipient of several awards including State Prize in Advanced Technological Sciences, Excellence in Research & Creative Endeavors Award (AUC), Global Innovator Award (Texas Christian University), and Arab Innovation & Entrepreneurship Award (UAE).